Table 2 Baseline characteristics stratified by HF status
Characteristics | Without HF | HF | P-value |
|---|---|---|---|
N = 9210 | N = 637 | ||
Age, years | 9210 (57) | 637 (70) | < 0.001 |
Sex, % | Â | Â | 0.642 |
 Men | 4503 (49.3) | 329 (50.6) |  |
 Women | 4707 (50.7) | 308 (49.4) |  |
Race and ethnicity, % | Â | Â | 0.266 |
 Non-Hispanic White | 4259 (71.3) | 338 (72.2) |  |
 Hispanic | 1329 (5.5) | 67 (3.8) |  |
 Non-Hispanic Black | 2223 (12.7) | 153 (14.1) |  |
 Otherb | 1399 (10.6) | 79 (9.9) |  |
Education attainment, % |  |  | < 0.001 |
 <High school | 1275 (7.1) | 132 (14.4) |  |
 High school | 3709 (38.5) | 283 (47.5) |  |
 >High school | 4216 (54.4) | 221 (38.1) |  |
Smoking, % | 1699 (19) | 113 (19.2) | 0.906 |
Alcohol consumption, % | 5220 (69.2) | 266 (48.5) | < 0.001 |
BMI, kg/m2 | 9210 (29.6) | 637 (30) | 0.051 |
TC, mmol/L | 9210 (5.1) | 637 (4.7) | < 0.001 |
TG, mmol/L | 9210 (1.3) | 637 (1.5) | 0.0506 |
HDL-C, mmol/L | 9209 (1.3) | 637 (1.2) | < 0.001 |
LDL-C, mmol/L | 8835 (2.9) | 598 (2.5) | < 0.001 |
Haemoglobin, mg/dL | 9194 (14.4) | 634 (13.8) | < 0.001 |
Albumin, g/L | 9174 (42) | 635 (41) | < 0.001 |
eGFR, mL/min/1.73 m2 | 9173 (85.7) | 634 (67.2) | < 0.001 |
FBG, mmol/L | 9210 (5.7) | 637 (6.2) | < 0.001 |
TyG | 9210 (8.8) | 637 (8.9) | < 0.001 |
TyG-BMI | 9210 (262.5) | 637 (272.1) | 0.004 |
HbA1c, % | 9210 (5.6) | 637 (5.9) | < 0.001 |
Predictive HbA1c, % | 9210 (5.7) | 637 (5.9) | < 0.001 |
HGI | 9210 -(0.1) | 637 (0) | < 0.001 |
Hypoglycemic drugs, % | 1670 (14.7) | 222 (33.7) | < 0.001 |
Lipid-lowering drugs, % | 2833 (30.6) | 360 (58.8) | < 0.001 |
Antihypertensive drugs, % | 2062 (21.4) | 147 (22.3) | 0.731 |
CHD | 527 (5.4) | 237 (39.3) | < 0.001 |
Diabetic status |  |  | < 0.001 |
 Normoglycemia | 2685 (33.3) | 105 (15.4) |  |
 Prediabetes | 4848 (51.6) | 327 (52.8) |  |
 Diabetes | 1677 (15.1) | 205 (31.8) |  |